SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-028507
Filing Date
2024-07-19
Accepted
2024-07-19 16:05:37
Documents
16
Period of Report
2024-07-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52509
2 ex10-1.htm EX-10.1 44099
3 ex10-2.htm EX-10.2 20887
4 ex10-3.htm EX-10.3 32108
  Complete submission text file 0001493152-24-028507.txt   345991

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE pulm-20240715.xsd EX-101.SCH 3018
6 XBRL LABEL FILE pulm-20240715_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE pulm-20240715_pre.xml EX-101.PRE 22361
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3685
Mailing Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701
Business Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701 (888) 355-4440
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 241127856
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)